---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-008972"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:08:53.996572+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Revelation Biosciences posts updated corporate presentation; no material new details disclosed

## Summary
- Presentation dated Jan 30, 2024, posted on company website; no financial or pipeline specifics in filing.
- Company focuses on developing innovative therapeutics for unmet medical needs.
- No guidance, milestones, or material events announced in the presentation.

## SEC filing metadata
- accession: 0000950170-24-008972
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017024008972/0000950170-24-008972-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024008972/revb-20240130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-008972
- JSON: https://secwatch.observer/filing/0000950170-24-008972.json
- Plain text: https://secwatch.observer/filing/0000950170-24-008972.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.